Issue #20 • July 25, 2025
Hi Seedradar Squad! This week's innovation scene reveals that TCG Labs Soleil has secured substantial funding to launch narrowly focused biotechnology companies. Simultaneously, Hadrian raised significant capital to scale its AI-powered aerospace and defense factories.
Alongside these major announcements, Dispatch Bio emerged from stealth with substantial backing for universal immunotherapy, and Reka AI rapidly increased its valuation with new funding from NVIDIA and Snowflake for its multimodal AI models. Prepare to explore a dynamic array of emerging startups in fintech, health tech, and clean tech, as new possibilities are constantly taking shape.
Image courtesy of The Business Journals
TCG Labs Soleil, a venture firm that builds narrowly focused biotechnology startups, announced it has raised $400 million to continue launching new companies. This brings the firm's total capital raised to $800 million since its 2024 launch in collaboration with The Column Group.
The firm operates a venture-biotech model with its own R&D hub, creating a portfolio of single-drug companies and positioning them for partnerships once they achieve proof-of-concept data. Since its formation, TCG Labs Soleil has founded 10 portfolio companies pursuing drugs for cancer, immune diseases, and other conditions.
Hadrian, a developer of AI-enabled factories for aerospace and defense manufacturing, announced it raised $260 million in a Series C round. The financing was led by existing investors Founders Fund and Lux Capital and includes a factory expansion loan facility arranged by Morgan Stanley.
The new funding will help open nearly five football fields' worth of new factory space in Arizona and California. The expansion includes a new division, Hadrian Maritime, focused on applying its autonomous factory model to shipbuilding and naval defense supply chains.
• Dispatch Bio launched from stealth with $216 million in combined seed and Series A funding to develop a universal immunotherapy for solid tumors. The company was formed in 2022 through a collaboration between ARCH Venture Partners and the Parker Institute for Cancer Immunotherapy. - Read More
• Vanta has raised $150 million in a Series D round, boosting its valuation to $4.15 billion. The round was led by Wellington Management with participation from existing backers including Goldman Sachs Alternatives and Sequoia. - Read More
• Reka AI has raised $110 million in new funding backed by NVIDIA and Snowflake. The round triples the company's valuation to $1 billion. Reka develops efficient models like Reka Flash, a 21-billion-parameter model that can understand video, images, text, and audio. - Read More
• Yieldstreet announced a $77 million capital raise. The funding round was led by Tarsadia Investments, with support from existing investors and new backer RedBird Capital Partners. The platform provides retail and accredited investors with opportunities in asset classes such as real estate, corporate credit, and private equity. - Read More
️🔥 Alkeon Capital- Led a $50 million Series D funding round for Ashby, an AI-powered hiring and recruitment platform that has more than doubled its customer base in the past year. - Read More
️🔥 Insight Partners- Led a $40 million Series B funding round for Trunk Tools, an AI-powered platform designed to help construction teams interact with and manage project data. - Read More
️🔥 QED Investors- Led a $38 million Series B funding round for April, an embedded AI tax platform that helps users forecast, optimize, and file taxes through financial apps. - Read More
️🔥 Human Capital- Led a $24 million Series A funding round for Rune Technologies, a startup using an AI-driven software platform to modernize logistics for the U.S. military. - Read More
|
|
|
⚖️ Clerky's Startup Formation & Equity Management Platform
The gold-standard online legal service for high-growth startups, providing attorney-grade documents and workflows for incorporation, post-incorporation setup, cap table management, and founder agreements. Using Clerky ensures a clean, venture-ready legal structure, de-risking future fundraising and satisfying investor due diligence requirements for 2025.
Reply